Need Help?

THL Biobank Data Access Committee

Contact Information

THL Biobank DAC
admin.biobank@thl.fi

Request Access

This DAC controls 8 datasets

Dataset ID	Description	Technology	Samples
EGAD00000000026	Randomly-selected, unrelated individuals	Illumina 610-Quad	518
EGAD00001000055	Genetic variation in Kuusamo	Illumina HiSeq 2000	434
EGAD00001000200	Dilgom Exome	Illumina HiSeq 2000	130
EGAD00001000299	Whole exome sequencing of samples selected from the Finrisk sample collection. The samples sequenced in this study have all been collected in Kuusamo, Finland.	Illumina HiSeq 2000	24
EGAD00001000403	The ENGAGE project is a FP7 funded EU project aiming to combine genetic and phenotype information from European population based cohorts. In this sub-project we aim to do whole exome sequencing of individuals selected from Health 2000 and FINRISK cohorts. Individuals have been selected based on their metabolic trait phenotypes	Illumina HiSeq 2000	394
EGAD00001001250	Low coverage (4-6x) sequencing on samples from population cohorts (Finrisk, Health2000) will be done at Wellcome Trust Sanger Institute (WTSI) using Illumina HiSeq sequencing technology. We will produce 100bp paired end reads. Variants will be called using the 1000 Genomes Project pipeline. The samples have been selected from a national representative set of 8028 samples from persons of 30 years or older, which were screened for psychotic and bipolar disorders using the Composite International Diagnostic Interview, self-reported diagnoses, medical examination, and national registers.	Illumina HiSeq 2000	731
EGAD00001001251	Low coverage (4-6x) sequencing on samples from population cohorts (Finrisk, Health2000) will be done at Wellcome Trust Sanger Institute (WTSI) using Illumina HiSeq sequencing technology. We will produce 100bp paired end reads. Variants will be called using the 1000 Genomes Project pipeline. The samples have been selected from a national representative set of approximately 30,300 samples and comprises 500 individuals of each gender in the extreme tail of high density lipoprotein (HDL) concentrations. Included individuals were between 25 and 65 years of age. Individuals with a diagnosis of diabetes or BMI>30 were excluded from the study.	Illumina HiSeq 2000	966
EGAD00010000662	Finnish population cohort genotyping		-